Consequently, they combined the agonist with an anti‐PD‐1 antibody, highlighting the importance of immune priming to increase treatment response.[77] The NC NF‐κB pathway can result in the secretion of tumor‐growth supporting cytokines such as IL‐6. The gene discussed is NFKB1; the disease is neoplasm.